Ftse Mib
36.049,36
-0,26%
DAX
21.042,00
0,18%
S&P 500
6.041,22
0,74%
NASDAQ
19.764,93
0,69%
Bitcoin
106.535,63
4,42%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Incyte Corporation (INCY) Incyte Corporation (INCY) Notizie

Incyte Corporation

INCY
73,45
1,52 (2,11%)
Ultimo aggiornamento: 20:26:46
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/1/202514:00BWIncyte to Report Fourth Quarter and Year-End 2024 Financial..
17/1/202521:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202521:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202521:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202521:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/1/202523:34PRNUSIncyte and Syndax Announce U.S. Food and Drug Administration..
13/1/202514:30BWIncyte Highlights Commercial Growth, Clinical Progress and..
10/1/202514:11EDGAR2Form 8-K - Current report
09/1/202500:30BWIncyte Reports Inducement Grants Under Nasdaq Listing Rule..
08/1/202522:41BWIncyte Reports Inducement Grants Under Nasdaq Listing Rule..
08/1/202522:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202522:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/1/202523:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202519:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202519:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202418:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202414:00BWIncyte to Present at Upcoming Investor Conference
16/12/202422:04EDGAR2Form 144 - Report of proposed sale of securities
12/12/202418:07BWAktuelle Incyte Tafasitamab (Monjuvi® ) Daten demonstrieren..
12/12/202418:03BWLes données de dernières minutes d'Incyte sur le tafasitamab..
11/12/202419:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202419:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202416:30BWIncyte Late-Breaking Tafasitamab (Monjuvi®) Data at ASH 2024..
07/12/202413:30BWIncyte Announces Positive Results from Phase 3 Trial..
06/12/202422:30BWIncyte Reports Inducement Grants Under Nasdaq Listing Rule..
03/12/202418:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202419:28EDGAR2Form 144 - Report of proposed sale of securities
26/11/202422:10BWIncyte Announces Updated Presentation Time for Upcoming..
26/11/202412:29BWIncyte stellt auf der ASH-Jahrestagung 2024 neue Daten vor,..
26/11/202412:28BWIncyte présentera de nouvelles données lors de la réunion..
25/11/202416:09BWIncyte to Spotlight New Data, Including a Late Breaking Oral..
18/11/202422:30BWIncyte Provides Update on Early Phase MRGPRX2 and MRGPRX4..
14/11/202414:00BWIncyte to Present at Upcoming Investor Conference
08/11/202418:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202422:30BWIncyte Reports Inducement Grants Under Nasdaq Listing Rule..
06/11/202422:15EDGAR2Form 144 - Report of proposed sale of securities
30/10/202413:00BWIncyte to Present at Upcoming Investor Conferences
29/10/202421:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/10/202412:05EDGAR2Form 8-K - Current report
29/10/202412:00BWIncyte Reports 2024 Third Quarter Financial Results and..
24/10/202420:03BWIncyte Named One of Top 5 Companies on Science Magazine’s..
21/10/202422:11EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
15/10/202414:30GLOBEKnight Therapeutics Announces Approval of Minjuvi®..
10/10/202415:15BWIncyte Furthers Commitment to People Living with Atopic..
08/10/202414:00BWIncyte to Report Third Quarter Financial Results
08/10/202405:08BWIncyte Reports Inducement Grants Under Nasdaq Listing Rule..
04/10/202418:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202422:30BWIncyte Reports Inducement Grant Under Nasdaq Listing Rule..
03/10/202419:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202419:24EDGAR2Form 3 - Initial statement of beneficial ownership of..
Apertura: 71,95 Min: 71,95 Max: 73,98
Chiusura: 71,93

La tua Cronologia

NASDAQ
INCY
Incyte
ASX
WPR
Waypoint REIT
TSX
LS
Middlefield Healthcare a...
BOV
PMAM3M
PARANAPANEMA ON
BOV
BRGE3R
ALFA CONSORCIO ON
BIT
MEUD
ETF
TSXV
LI.WT
American Lithium
TG
D2GA
Orsted AS
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network